Utilization of iMRI for Transsphenoidal Resection of Pituitary Macroadenomas
NCT ID: NCT02396810
Last Updated: 2023-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2015-05-19
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endocrine Outcome of Surgery for Pituitary Adenoma
NCT03515603
Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas
NCT03542409
Fluorescein vs. iMRI in Resection of Malignant High Grade Glioma
NCT02540135
Prediction of Sphenoid Septation in MRI Compared With CT and Intraoperative Findings During Endoscopic Pituitary Adenoma Surgery
NCT03624114
1.5T Intraoperative MR Imaging in Craniopharyngiomas
NCT01206543
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No intra-operative MRI
Patients undergo transsphenoidal surgery without an intra-operative MRI.
Transsphenoidal resection of pituitary macroadenoma
Routine transsphenoidal resection of pituitary macro adenomas
intra-operative MRI
Patients undergo transspheonidal surgery followed by intra-operative MRI.
intra-operative MRI
Intra-operative magnetic resonance imaging under general anesthesia
Transsphenoidal resection of pituitary macroadenoma
Routine transsphenoidal resection of pituitary macro adenomas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intra-operative MRI
Intra-operative magnetic resonance imaging under general anesthesia
Transsphenoidal resection of pituitary macroadenoma
Routine transsphenoidal resection of pituitary macro adenomas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of giving informed consent
* Elect for transsphenoidal surgery
* Has pre-operative MRI demonstrating pituitary tumor that is:
1. deemed resectable using a transsphenoidal approach and
2. has a maximal diameter equal to or greater than 15 mm.
* No contraindications for MRI.
Exclusion Criteria
* Not able to give consent
* No pituitary tumor visible on MRI or an adenoma measuring less than 15mm in maximal dimension.
* Unable to tolerate MRI
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dartmouth-Hitchcock Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nathan E. Simmons
Staff Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00028376 D14236
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.